HomeMCRB • NASDAQ
add
Seres Therapeutics Inc
Nakaraang pagsara
$0.85
Sakop ng araw
$0.83 - $0.91
Sakop ng taon
$0.54 - $1.53
Market cap
144.15M USD
Average na Volume
2.42M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 26.22M | -34.20% |
Net na kita | 88.78M | 285.51% |
Net profit margin | — | — |
Kita sa bawat share | -0.33 | 10.81% |
EBITDA | -27.77M | 35.28% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 66.82M | -60.67% |
Kabuuang asset | 178.74M | -51.39% |
Kabuuang sagutin | 154.82M | -59.56% |
Kabuuang equity | 23.92M | — |
Natitirang share | 170.74M | — |
Presyo para makapag-book | 6.07 | — |
Return on assets | -29.14% | — |
Return on capital | -60.00% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 88.78M | 285.51% |
Cash mula sa mga operasyon | -34.68M | 41.47% |
Cash mula sa pag-invest | 141.14M | 7,954.37% |
Cash mula sa financing | -110.87M | -7,783.37% |
Net change in cash | -4.41M | 92.61% |
Malayang cash flow | 18.02M | 143.78% |
Tungkol
CEO
Itinatag
2010
Website
Mga Empleyado
233
